首页> 外文期刊>Parasitology Research >Adjuvant effect of ginsenoside-based nanoparticles (ginsomes) on the recombinant vaccine against Eimeria tenella in chickens
【24h】

Adjuvant effect of ginsenoside-based nanoparticles (ginsomes) on the recombinant vaccine against Eimeria tenella in chickens

机译:人参皂甙纳米颗粒(人参体)对鸡抗艾美球虫重组疫苗的佐剂作用

获取原文
获取原文并翻译 | 示例
           

摘要

An experiment was conducted to study the adjuvant effect of ginsomes on the recombinant profilin in coccidian-infected breeding birds. Three-day-old chickens were vaccinated with Eimeria tenella recombinant profilin antigen (10, 50, and 100 μg per chicken) with or without 50 μg ginsomes per chicken. The boost vaccination was carried out 14 days later. Two weeks after the booster, the chickens were challenged with 1.5×10 4 homologous sporulated oocysts. The specific antibody response, lymphocyte proliferation, and IL-1 release from lymphocyte were measured at 1-42 days after boost vaccination. Seven days postchallenge, the rate of survival, body weight gains (BWG) were examined then all chickens were sacrificed and lesion scores and oocysts per gram were monitored to evaluate the protective effects of the vaccination after challenge. Compared with the group of vaccinating with profilin only, groups of 50 and 100 μg antigen plus ginsomes significantly enhanced lymphocyte proliferation and IL-1 secretion. The profilin specific antibody level in the four vaccinated groups was significantly higher than in the control group and in groups vaccinated with profilin containing ginsomes than profilin only. In the groups vaccinated with profilin plus ginsomes, the BWG was significantly higher than that of group of profilin only, but there was no significant difference between profilin plus adjuvant ginsomes, diclazuril medicated and uninfected-unmedicated-unvaccinated control groups. The lesion scores in groups immunized with profilin plus ginsomes was significantly lower than that both of groups unimmunized-challenged-unmedicated control and group vaccinated with profilin only. Oocyst excretion in groups vaccinated with 50 or 100 μg profilin plus ginsomes was lower than that of groups vaccinated with profilin only. These results demonstrate that the adjuvant ginsomes can promote subunit vaccine to induce a strong immune response and protective effects.
机译:进行了一项实验,以研究人参对球虫感染的种禽中重组蛋白纤溶酶的佐剂作用。给三天大的鸡接种艾美耳球虫重组蛋白纤溶蛋白抗原(每只鸡10、50和100μg),每只鸡含或不含50μg人参。 14天后进行加强免疫。加强免疫后两周,用1.5×10 4个同源带孢子卵囊攻击鸡。在加强免疫后1-42天测量特异性抗体应答,淋巴细胞增殖和IL-1从淋巴细胞释放。攻击后7天,检查存活率,体重增加(BWG),然后处死所有鸡,并监测损伤分数和每克卵囊,以评估攻击后疫苗的保护作用。与仅接种蛋白纤溶酶的组相比,50和100μg抗原加人参体的组显着增强了淋巴细胞的增殖和IL-1的分泌。在四个接种组中,profilin特异性抗体水平显着高于对照组,而在接种含profilin的人脂质体的组中,profilin特异性抗体水平高于仅profilin。在用蛋白前体蛋白加人参体接种的组中,BWG明显高于仅用蛋白前体素的组,但是,在用蛋白前体素和佐剂人参体,地克珠利加药和未感染,未用药,未接种疫苗的对照组之间,BWG没有显着差异。用profilin加人参体免疫的组的病变评分显着低于未免疫挑战的非药物对照组和仅接种profilin的组。接种了50或100μg脯氨酰胺的人加人参体的组的卵囊排泄率低于仅接种了profilin的组的。这些结果表明,佐剂型人佐剂可以促进亚单位疫苗诱导强烈的免疫反应和保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号